Vaculug has taken another significant step in its mission to support global communities by deploying another bicycle ambulance in Zambia. This latest initiative, delivered in collaboration with Transaid, will enhance emergency medical transport for pregnant women experiencing complications and children suffering from severe malaria.
As part of Vaculug’s Abundance Africa initiative, this deployment reflects the company’s commitment to improving healthcare access in remote regions, where traditional transport options are scarce.
In many rural areas of Zambia, healthcare facilities are often located miles away from villages, and access to motorised transport is extremely limited. For critically ill patients, particularly pregnant women and young children, the lack of transportation can mean the difference between life and death.
To bridge this gap, Vaculug’s bicycle ambulances are designed to navigate rough terrain, providing a crucial link between rural communities and healthcare facilities. These specially built ambulances are used by Emergency Transport Riders (ETRs), who are trained to cycle patients to medical centres quickly and safely.
Vaculug’s efforts are bolstered by its partnership with Transaid, a UK-based charity that specialises in improving transport solutions for healthcare access. Transaid has been actively deploying bicycle ambulances across Zambia as part of various health initiatives, significantly reducing mortality rates from malaria and maternal complications.
The latest Vaculug-branded bicycle ambulance represents another critical investment in rural healthcare, ensuring that more patients receive the urgent medical attention they need.
Through its Abundance Africa programme, Vaculug continues to make a tangible difference in people’s lives, demonstrating that corporate social responsibility can drive real, lasting change.
Editorial Standards & Disclaimer
Tyre News Media is an independent industry publication. Our reporting is based on information available at the time of publication, including company announcements, regulatory filings, official data, research and other sources considered reliable.
Articles may include independent analysis and editorial interpretation. Where appropriate, company statements and third-party claims are attributed to their source. Analysis, estimates and forward-looking observations should not be read as statements of established fact.
Tyre News Media takes reasonable steps to ensure accuracy but welcomes corrections, clarifications and responses from organisations or individuals covered in our reporting. If you believe information is inaccurate or requires clarification, please contact info@tyrenews.co.uk. Material errors will be corrected as appropriate.
Commercial relationships, advertising and sponsorship do not determine Tyre News Media's editorial coverage or conclusions.
_0%20(1).png)
.png)
.jpeg)
